Leukocyte Interleukin, Injection

Phase 1Terminated

0 views this week 0 watching💤 Quiet

Interest: 11/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Perianal Warts

Conditions

Perianal Warts

Trial Timeline

Apr 1, 2015 → Sep 1, 2018

NCT ID

NCT03038828

About Leukocyte Interleukin, Injection

Leukocyte Interleukin, Injection is a phase 1 stage product being developed by CEL-SCI for Perianal Warts. The current trial status is terminated. This product is registered under clinical trial identifier NCT03038828. Target conditions include Perianal Warts.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT03038828	Phase 1	Terminated	Apr 1, 2015	Sep 1, 2018	Perianal Warts